These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 22095533)
1. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana. Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533 [TBL] [Abstract][Full Text] [Related]
2. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944 [TBL] [Abstract][Full Text] [Related]
3. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. Gupta S; Singh S BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948 [TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM; J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317 [TBL] [Abstract][Full Text] [Related]
9. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana. Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687 [TBL] [Abstract][Full Text] [Related]
10. [Investigation of occult hepatitis B in HIV infected patients]. Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079 [TBL] [Abstract][Full Text] [Related]
11. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana. Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. Pirillo MF; Bassani L; Germinario EA; Mancini MG; Vyankandondera J; Okong P; Vella S; Giuliano M J Med Virol; 2007 Dec; 79(12):1797-801. PubMed ID: 17935164 [TBL] [Abstract][Full Text] [Related]
16. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185 [TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029 [TBL] [Abstract][Full Text] [Related]
18. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]. Smit MC; Haverkamp MH; Weersink AJ; Boucher CA; Hoepelman IM Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2330-4. PubMed ID: 15587052 [TBL] [Abstract][Full Text] [Related]
19. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006 [TBL] [Abstract][Full Text] [Related]
20. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals. Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]